For people living with migraine, better control is not only about stopping pain. Stress, changing headaches, incomplete relief, access barriers, and the ability to function day to day can all shape whether a treatment plan feels sustainable.
Audience: Migraine patients
Countries: 6
Completion Rate: 70.9%
SGID: 9018502
-Hero findings
– Quick Read — Key Findings
More than half of respondents identify stress or anxiety as the factor that most often worsens their migraine.
Stress or anxiety is the factor most often chosen as worsening migraine at 53.6%, well ahead of hormonal changes (16.4%), sleep disruption (15.5%) and light or noise triggers (14.5%). This does not mean stress causes migraine, a neurological disease with person-specific triggers, but it shows how strongly patients link emotional strain to their attack pattern, echoing the American Migraine Foundation’s note that stress, sleep, diet and hydration can all influence attacks.
Worsening or changing headaches are the dominant reason respondents say further migraine evaluation was prompted.
Worsening or changing headaches most often prompt further evaluation at 59.1%, ahead of increasing disability (23.6%), new neurological symptoms (12.7%) and no evaluation needed (4.5%). A change in the familiar migraine pattern is clearly a strong signal for patients, which is why people need clear advice on when a new pattern, rising disability or new symptoms should be discussed promptly with a clinician.
Over-the-counter pain medicine is the most common first choice during a migraine attack.
Over-the-counter pain medicine is the most common first acute choice at 43.6%, ahead of triptans (28.2%), gepant or CGRP-targeted treatment (15.5%) and rest or trigger avoidance (12.7%). The first action during an attack is often shaped by familiarity, availability and speed, which makes it important to know which acute treatment fits, when to take it, and when frequent reliance on acute medication needs clinical review.
Stress or anxiety remains uncontrolled for 39.4%, ahead of incomplete symptom relief and medication side effects.
Uncontrolled stress or anxiety is the biggest limit on current treatment at 39.4%, ahead of incomplete symptom relief (30.3%), side effects (19.3%) and medication-overuse or rebound headache (11.0%). This loops back to the trigger data: stress is not only described as worsening attacks, it also remains the largest unresolved problem within treatment, so for some patients migraine and emotional wellbeing may need to be addressed together rather than in separate appointments.
40.7% say treatment was not escalated after inadequate migraine control.
The largest group (40.7%) report that treatment was not escalated after inadequate control, while 37.0% started an oral preventive, 13.0% added a CGRP-targeted therapy and 9.3% started onabotulinumtoxinA. The survey does not say why escalation did not happen, but from the patient view it raises a practical question: when control is still poor, is there a clear next-step conversation?
Better daily functioning is the leading influence on staying with preventive migraine treatment.
Better daily functioning is the strongest reason patients give for staying on preventive treatment at 44.4%, ahead of fewer monthly migraine days (33.3%), fewer side effects (12.0%) and an easier routine (10.2%). Attack frequency matters, but people also judge treatment by whether they can work, sleep, make plans and get through the day, so a clinically effective treatment can still feel unsuccessful if everyday life does not improve enough.
Migraine care can become fragmented when pain, prevention, stress, sleep, access and everyday functioning are treated as separate problems, yet patients connect these pieces themselves: stress or anxiety is the leading factor worsening migraine, the leading limitation of current treatment is also uncontrolled stress or anxiety, and better daily functioning is the strongest reason people give for staying on preventive care.
The data also shows friction after poor control: a sizeable group remains untreated, over-the-counter medicines are the most common first action, and the largest group reports no escalation after inadequate control, while cost and insurance coverage emerge as the most frequently selected barrier to migraine or mental-health care.
You have read the summary
Dive deeper into the research, or take part in future studies that turn real healthcare perspectives into meaningful insights.
Direct answers to common patient questions about migraine triggers, treatment review, prevention, and daily management.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
